Harbin Pharmaceutical

Harbin Pharmaceutical is a company listed under the stock ticker 600664 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Harbin Pharmaceutical

• Weihong Lu, Independent Director
• Aidong Lou, Independent Director
• Shiwei Yin, Director

Create your alert
to follow the executive moves at Harbin Pharmaceutical.

Harbin Pharmaceutical has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Harbin Pharmaceutical

• 核心资讯
• LinkedIn Login, Sign in | LinkedIn

Social media about Harbin Pharmaceutical

• Harbin Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Harbin Pharmaceutical on LinkedIn, Twitter & YouTube

Call Harbin Pharmaceutical at +86 451 ...

View the org chart

Register to receive your alert

Report an error